In the setting of COVID-19, would you perform a SLNB for a patient incidentally found to have microinvasive ER+ ILC in contralateral prophylactic mastectomy following neoadjuvant chemotherapy for a locally advanced triple positive breast cancer?

Topics: Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Her2+ • Columbia • HR+ • COVID-19 • NCI-CCC Breast Tumor Board Question

Answer from: Medical Oncologist at Academic Institution

I would not recommend SLN biopsy, independent of COVID-19. This patient's prognosis is overwhelmingly dependent on the locally advanced triple negative breast cancer, not the microinvasive ER positive breast cancer. Acknowledging that the ER positive cancer may have been larger than microinvasive b...

Comments

Medical Oncologist
I am not a surgeon, but technically how would a SL...

Answer from: Medical Oncologist at Community Practice

It won't change her course of treatment so I would not.

Related Questions